Login

BVZ Holding CEO Fernando Lehner on H1 2022, Future Projects, and Motivating His Team Amidst Challenges | Fernando Lehner - CEO of bvz holding ag 00:10:00

Share On Facebook Share On Twitter

Fernando Lehner is the CEO of bvz holding ag

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Streamline Your Supply Chain with Atkore Regional Service Centers
00:10:00
Cesar Gon, CEO of CI&T, says 'We are living through a technological revolution' in O Globo.
00:10:00
Spotlight on Eric Zaunscherb: Chairman of Critical Elements Lithium Corp. | Eric Zaunscherb ,Chairman of Critical Elements Lithium Corporation
00:10:00
Building a Future We Wish Existed|Andrew Beebe,Managing Director,Obvious Ventures
00:10:00
F&C Lecture: Navigating Alternative Investments | Paul Niven, Manager, F&C Investment Trust
00:10:00
Optimizing CareRx's Future: CEO Puneet Khanna Shares Strategic Vision and Financial Insights|Puneet Khanna, CEO, CareRx Corp.
00:10:00
Goldman Sachs Insights: Exploring Large Cap Investing with Jennison Associates' Kathleen McCarragher on Strategies, Trends, and Future Outlook
00:10:00
The Global Implications of Ukraine's Fight for Freedom|H.R. McMaster
00:10:00
Navigating Industrial Evolution: Meeting Demand, Managing Costs, and Innovating in Critical Services
00:10:00
Oregon needs a leader who will challenge conventional thinking, innovate, and make state government accountable to the taxpayer|Allen Alley,CEO,pixelworks inc
00:10:00
Building a Growth Machine|Brian Balfour,Venture Partner,Long Journey Ventures
00:10:00
Exploring the Dynamic Terrain of Global Digital Infrastructure | Marc Ganzi , CEO ,DigitalBridge Group Inc.

© 2017 - Neuhu+